LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article ; Online: Direct and indirect effects of Puumala hantavirus on platelet function.

    Schrottmaier, Waltraud C / Schmuckenschlager, Anna / Thunberg, Therese / Wigren-Byström, Julia / Fors-Connolly, Anne-Marie / Assinger, Alice / Ahlm, Clas / Forsell, Mattias N E

    Thrombosis research

    2023  Volume 233, Page(s) 41–54

    Abstract: Thrombocytopenia is a cardinal symptom of hantavirus-induced diseases including Puumala virus (PUUV)-induced hemorrhagic fever with renal syndrome (HFRS), which is associated with impaired platelet function, bleeding manifestations and augmented ... ...

    Abstract Thrombocytopenia is a cardinal symptom of hantavirus-induced diseases including Puumala virus (PUUV)-induced hemorrhagic fever with renal syndrome (HFRS), which is associated with impaired platelet function, bleeding manifestations and augmented thrombotic risk. However, the underlying mechanisms causing thrombocytopenia and platelet hypo-responsiveness are unknown. Thus, we investigated the direct and indirect impact of PUUV on platelet production, function and degradation. Analysis of PUUV-HFRS patient blood revealed that platelet hypo-responsiveness in PUUV infection was cell-intrinsic and accompanied by reduced platelet-leukocyte aggregates (PLAs) and upregulation of monocyte tissue factor (TF), whereas platelet vasodilator-stimulated phosphoprotein (VASP) phosphorylation was comparable to healthy controls. Plasma CXCL4 levels followed platelet count dynamics throughout disease course. PUUV activated both neutrophils and monocytes in vitro, but platelet desialylation, degranulation and GPIIb/IIIa activation as well as PLA formation and endothelial adhesion under flow remained unaltered in the presence of PUUV. Further, MEG-01 megakaryocytes infected with PUUV displayed unaltered polyploidization, expression of surface receptors and platelet production. However, infection of endothelial cells with PUUV significantly increased platelet sequestration. Our data thus demonstrate that although platelet production, activation or degradation are not directly modulated, PUUV indirectly fosters thrombocytopenia by sequestration of platelets to infected endothelium. Upregulation of immunothrombotic processes in PUUV-HFRS may further contribute to platelet dysfunction and consumption. Given the pathophysiologic similarities of hantavirus infections, our findings thus provide important insights into the mechanisms underlying thrombocytopenia and highlight immune-mediated coagulopathy as potential therapeutic target.
    MeSH term(s) Humans ; Puumala virus ; Hemorrhagic Fever with Renal Syndrome/diagnosis ; Hemorrhagic Fever with Renal Syndrome/therapy ; Endothelial Cells ; Orthohantavirus ; Thrombocytopenia
    Language English
    Publishing date 2023-11-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2023.11.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Hybrid capture-based next-generation sequencing of new and old world Orthohantavirus strains and wild-type Puumala isolates from humans and bank voles.

    Rosenbaum, William / Bovinder Ylitalo, Erik / Castel, Guillaume / Sjödin, Andreas / Larsson, Pär / Wigren Byström, Julia / Forsell, Mattias N E / Ahlm, Clas / Pettersson, Lisa / Tuiskunen Bäck, Anne

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2024  Volume 172, Page(s) 105672

    Abstract: Orthohantaviruses, transmitted primarily by rodents, cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus pulmonary syndrome in the Americas. These viruses, with documented human-to-human transmission, exhibit a wide case-fatality ...

    Abstract Orthohantaviruses, transmitted primarily by rodents, cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus pulmonary syndrome in the Americas. These viruses, with documented human-to-human transmission, exhibit a wide case-fatality rate, 0.5-40 %, depending on the virus species, and no vaccine or effective treatment for severe Orthohantavirus infections exists. In Europe, the Puumala virus (PUUV), carried by the bank vole Myodes glareolus, causes a milder form of HFRS. Despite the reliance on serology and PCR for diagnosis, the three genomic segments of Swedish wild-type PUUV have yet to be completely sequenced. We have developed a targeted hybrid-capture method aimed at comprehensive genomic sequencing of wild-type PUUV isolates and the identification of other Orthohantaviruses. Our custom-designed panel includes >11,200 probes covering the entire Orthohantavirus genus. Using this panel, we sequenced complete viral genomes from bank vole lung tissue, human plasma samples, and cell-cultured reference strains. Analysis revealed that Swedish PUUV isolates belong to the Northern Scandinavian lineage, with nucleotide diversity ranging from 2.8 % to 3.7 % among them. Notably, no significant genotypic differences were observed between the viral sequences from reservoirs and human cases except in the nonstructural protein. Despite the high endemicity of PUUV in Northern Sweden, these are the first complete Swedish wild-type PUUV genomes and substantially increase our understanding of PUUV evolution and epidemiology. The panel's sensitivity enables genomic sequencing of human samples with viral RNA levels reflecting the natural progression of infection and underscores our panel's diagnostic value, and could help to uncover novel Orthohantavirus transmission routes.
    Language English
    Publishing date 2024-03-30
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2024.105672
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Clinical and genomic characterisation of a fatal Puumala orthohantavirus case with low levels of neutralising antibodies.

    Tuiskunen Bäck, Anne / Rasmuson, Johan / Thunberg, Therese / Rankin, Gregory / Wigren Byström, Julia / Andersson, Charlotta / Sjödin, Andreas / Forsell, Mattias / Ahlm, Clas

    Infectious diseases (London, England)

    2022  Volume 54, Issue 10, Page(s) 766–772

    Abstract: Background: Orthohantaviruses are rodent-borne emerging viruses that cause haemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus pulmonary syndrome in America. Transmission between humans have been reported and the case-fatality rate ... ...

    Abstract Background: Orthohantaviruses are rodent-borne emerging viruses that cause haemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus pulmonary syndrome in America. Transmission between humans have been reported and the case-fatality rate ranges from 0.4% to 40% depending on virus strain. There is no specific and efficient treatment for patients with severe HFRS. Here, we characterised a fatal case of HFRS and sequenced the causing Puumala orthohantavirus (PUUV).
    Methods: PUUV RNA and virus specific neutralising antibodies were quantified in plasma samples from the fatal case and other patients with non-fatal PUUV infection. To investigate if the causing PUUV strain was different from previously known strains, Sanger sequencing was performed directly from the patient's plasma. Biopsies obtained from autopsy were stained for immunohistochemistry.
    Results: The patient had approximately tenfold lower levels of PUUV neutralising antibodies and twice higher viral load than was normally seen for patients with less severe PUUV infection. We could demonstrate unique mutations in the S and M segments of the virus that could have had an impact on the severity of infection. Due to the severe course of infection, the patient was treated with the bradykinin receptor inhibitor icatibant to reduce bradykinin-mediated vessel permeability and maintain vascular circulation.
    Conclusions: Our data suggest that bradykinin receptor inhibitor may not be highly efficient to treat patients that are at an advanced stage of HFRS. Low neutralising antibodies and high viral load at admission to the hospital were associated with the fatal outcome and may be useful for future predictions of disease outcome.
    MeSH term(s) Antibodies, Neutralizing ; Antibodies, Viral ; Bradykinin Receptor Antagonists ; Genomics ; Orthohantavirus/genetics ; Hemorrhagic Fever with Renal Syndrome ; Humans ; Puumala virus/genetics
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Bradykinin Receptor Antagonists
    Language English
    Publishing date 2022-06-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 2839775-7
    ISSN 2374-4243 ; 2374-4235
    ISSN (online) 2374-4243
    ISSN 2374-4235
    DOI 10.1080/23744235.2022.2076904
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters.

    Blom, Kim / Fjällström, Peter / Molnár, Christian / Åberg, Mikael / Vikström, Linnea / Wigren-Byström, Julia / Bennet, Louise / Widerström, Micael / Rasmussen, Gunlög / Klingström, Jonas / Forsell, Mattias N E / Johansson, Anders F

    The Lancet. Infectious diseases

    2023  Volume 23, Issue 10, Page(s) e393–e394

    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19 ; Nursing Homes
    Language English
    Publishing date 2023-09-13
    Publishing country United States
    Document type Letter
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(23)00548-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021.

    Beser, Jessica / Galanis, Ilias / Enkirch, Theresa / Kühlmann Berenzon, Sharon / van Straten, Edward / Duracz, Jan / Rapp, Marie / Zakikhany, Katherina / Mansjö, Mikael / Wigren Byström, Julia / Forsell, Mattias N E / Groenheit, Ramona / Tegmark Wisell, Karin / Bråve, Andreas

    Scientific reports

    2022  Volume 12, Issue 1, Page(s) 10816

    Abstract: A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April-May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel were included. Results showed that an estimated 32.6% of the population in ... ...

    Abstract A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April-May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel were included. Results showed that an estimated 32.6% of the population in Sweden had detectable levels of antibodies, and among non-vaccinated 20.1% had detectable levels of antibodies. We tested for differences in seroprevalence between age groups and by sex and estimated seroprevalence among previously infected participants by time since reporting.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Viral ; COVID-19/epidemiology ; Child ; Child, Preschool ; Humans ; Immunoglobulin G ; Middle Aged ; SARS-CoV-2 ; Seroepidemiologic Studies ; Sweden/epidemiology ; Young Adult
    Chemical Substances Antibodies, Viral ; Immunoglobulin G
    Language English
    Publishing date 2022-06-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-022-15183-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study.

    Vikström, Linnea / Fjällström, Peter / Gwon, Yong-Dae / Sheward, Daniel J / Wigren-Byström, Julia / Evander, Magnus / Bladh, Oscar / Widerström, Micael / Molnar, Christian / Rasmussen, Gunlög / Bennet, Louise / Åberg, Mikael / Björk, Jonas / Tevell, Staffan / Thålin, Charlotte / Blom, Kim / Klingström, Jonas / Murrell, Ben / Ahlm, Clas /
    Normark, Johan / Johansson, Anders F / Forsell, Mattias N E

    The Lancet regional health. Europe

    2023  , Page(s) 100646

    Abstract: Background: To inform future preventive measures including repeated vaccinations, we have searched for a clinically useful immune correlate of protection against fatal COVID-19 among nursing homes residents.: Methods: We performed repeated capillary ... ...

    Abstract Background: To inform future preventive measures including repeated vaccinations, we have searched for a clinically useful immune correlate of protection against fatal COVID-19 among nursing homes residents.
    Methods: We performed repeated capillary blood sampling with analysis of S-binding IgG in an open cohort of nursing home residents in Sweden. We analyzed immunological and registry data from 16 September 2021 to 31 August 2022 with follow-up of deaths to 30 September 2022. The study period included implementation of the 3rd and 4th mRNA monovalent vaccine doses and Omicron virus waves.
    Findings: A total of 3012 nursing home residents with median age 86 were enrolled. The 3rd mRNA dose elicited a 99-fold relative increase of S-binding IgG in blood and corresponding increase of neutralizing antibodies. The 4th mRNA vaccine dose boosted levels 3.8-fold. Half-life of S-binding IgG was 72 days. A total 528 residents acquired their first SARS-CoV-2 infection after the 3rd or the 4th vaccine dose and the associated 30-day mortality was 9.1%. We found no indication that levels of vaccine-induced antibodies protected against infection with Omicron VOCs. In contrast, the risk of death was inversely correlated to levels of S-directed IgG below the 20th percentile. The death risk plateaued at population average above the lower 35th percentile of S-binding IgG.
    Interpretation: In the absence of neutralizing antibodies that protect from infection, quantification of S-binding IgG post vaccination may be useful to identify the most vulnerable for fatal COVID-19 among the oldest and frailest. This information is of importance for future strategies to protect vulnerable populations against neutralization resistant variants of concern.
    Funding: Swedish Research Council, SciLifeLab via Knut and Alice Wallenberg Foundation, VINNOVA. Swedish Healthcare Regions, and Erling Persson Foundation.
    Language English
    Publishing date 2023-05-06
    Publishing country England
    Document type Journal Article
    ISSN 2666-7762
    ISSN (online) 2666-7762
    DOI 10.1016/j.lanepe.2023.100646
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden.

    Holm, Karin / Lundgren, Maria N / Kjeldsen-Kragh, Jens / Ljungquist, Oskar / Böttiger, Blenda / Wikén, Christian / Öberg, Jonas / Fernström, Nils / Rosendal, Ebba / Överby, Anna K / Wigren Byström, Julia / Forsell, Mattias / Landin-Olsson, Mona / Rasmussen, Magnus

    BMC research notes

    2021  Volume 14, Issue 1, Page(s) 440

    Abstract: Objective: Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the ... ...

    Abstract Objective: Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was to investigate if convalescent plasma is beneficial to hospitalized patients with COVID-19.
    Results: Hospitalized patients with confirmed COVID-19 and an oxygen saturation below 94% were randomized 1:1 to receive convalescent plasma in addition to standard of care or standard of care only. The primary outcome was number of days of oxygen treatment to keep saturation above 93% within 28 days from inclusion. The study was prematurely terminated when thirty-one of 100 intended patients had been included. The median time of oxygen treatment among survivors was 11 days (IQR 6-15) for the convalescent plasma group and 7 days (IQR 5-9) for the standard of care group (p = 0.4, median difference -4). Two patients in the convalescent plasma group and three patients in the standard of care group died (p = 0.64, OR 0.49, 95% CI 0.08-2.79). Thus no significant differences were observed between the groups. Trial registration ClinicalTrials NCT04600440, retrospectively registered Oct 23, 2020.
    MeSH term(s) COVID-19/therapy ; Convalescence ; Humans ; Immunization, Passive ; Oxygen Saturation ; SARS-CoV-2 ; Sweden
    Language English
    Publishing date 2021-12-04
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 2413336-X
    ISSN 1756-0500 ; 1756-0500
    ISSN (online) 1756-0500
    ISSN 1756-0500
    DOI 10.1186/s13104-021-05847-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: MAIT cell activation is associated with disease severity markers in acute hantavirus infection.

    Maleki, Kimia T / Tauriainen, Johanna / García, Marina / Kerkman, Priscilla F / Christ, Wanda / Dias, Joana / Wigren Byström, Julia / Leeansyah, Edwin / Forsell, Mattias N / Ljunggren, Hans-Gustaf / Ahlm, Clas / Björkström, Niklas K / Sandberg, Johan K / Klingström, Jonas

    Cell reports. Medicine

    2021  Volume 2, Issue 3, Page(s) 100220

    Abstract: Hantaviruses are zoonotic RNA viruses that cause severe acute disease in humans. Infected individuals have strong inflammatory responses that likely cause immunopathology. Here, we studied the response of mucosal-associated invariant T (MAIT) cells in ... ...

    Abstract Hantaviruses are zoonotic RNA viruses that cause severe acute disease in humans. Infected individuals have strong inflammatory responses that likely cause immunopathology. Here, we studied the response of mucosal-associated invariant T (MAIT) cells in peripheral blood of individuals with hemorrhagic fever with renal syndrome (HFRS) caused by Puumala orthohantavirus, a hantavirus endemic in Europe. We show that MAIT cell levels decrease in the blood during HFRS and that residual MAIT cells are highly activated. This activation correlates with HFRS severity markers.
    MeSH term(s) Adult ; Antibodies, Viral/blood ; Antigen-Presenting Cells/immunology ; Antigen-Presenting Cells/virology ; Biomarkers/metabolism ; Case-Control Studies ; Disease Progression ; Endothelial Cells/immunology ; Endothelial Cells/virology ; Female ; Gene Expression Regulation ; Hantavirus Infections/genetics ; Hantavirus Infections/immunology ; Hantavirus Infections/pathology ; Hantavirus Infections/virology ; Hemorrhagic Fever with Renal Syndrome/genetics ; Hemorrhagic Fever with Renal Syndrome/immunology ; Hemorrhagic Fever with Renal Syndrome/pathology ; Hemorrhagic Fever with Renal Syndrome/virology ; Humans ; Immunophenotyping ; Interferon Type I/genetics ; Interferon Type I/immunology ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Interleukin-10/genetics ; Interleukin-10/immunology ; Interleukin-6/genetics ; Interleukin-6/immunology ; Lymphocyte Activation ; Male ; Middle Aged ; Monocytes/immunology ; Monocytes/virology ; Mucosal-Associated Invariant T Cells/immunology ; Mucosal-Associated Invariant T Cells/virology ; Puumala virus/immunology ; Puumala virus/pathogenicity ; Severity of Illness Index
    Chemical Substances Antibodies, Viral ; Biomarkers ; IFNG protein, human ; IL10 protein, human ; IL6 protein, human ; Interferon Type I ; Interleukin-6 ; Interleukin-10 (130068-27-8) ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2021-03-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2666-3791
    ISSN (online) 2666-3791
    DOI 10.1016/j.xcrm.2021.100220
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Quantification and kinetics of viral RNA transcripts produced in Orthohantavirus infected cells

    Wigren Byström, Julia / Jonas Näslund / Fredrik Trulsson / Magnus Evander / Olivia Wesula Lwande / Clas Ahlm / Göran Bucht

    Virology journal. 2018 Dec., v. 15, no. 1

    2018  

    Abstract: BACKGROUND: Rodent borne viruses of the Orthohantavirus genus cause hemorrhagic fever with renal syndrome among people in Eurasia, and hantavirus cardiopulmonary syndrome in the Americas. At present, there are no specific treatments or efficient vaccines ...

    Abstract BACKGROUND: Rodent borne viruses of the Orthohantavirus genus cause hemorrhagic fever with renal syndrome among people in Eurasia, and hantavirus cardiopulmonary syndrome in the Americas. At present, there are no specific treatments or efficient vaccines against these diseases. Improved understanding of viral transcription and replication may instigate targeted treatment of Orthohantavirus infections. For this purpose, we investigated the kinetics and levels of viral RNA transcription during an ongoing infection in-vitro. METHODS: Vero E6 cells were infected with Puumala Orthohantavirus (strain Kazan) before cells and supernatants were collected at different time points post infection for the detection of viral RNAs. A plasmid containing primer binding sites of the three Orthohantavirus segments small (S), medium (M) and large (L) was constructed and standard curves were generated to calculate the copy numbers of the individual transcripts in the collected samples. RESULTS: Our results indicated a rapid increase in the copy number of viral RNAs after 9 h post infection. At peak days, 2–6 days after infection, the S- and M-segment transcripts became thousand and hundred-fold more abundant than the copy number of the L-segment RNA, respectively. The presence of viral RNA in the cell culture media was detected at later time-points. CONCLUSIONS: We have developed a method to follow RNA transcription in-vitro after synchronous infection of Vero cells. The obtained results may contribute to the understanding of the viral replication, and may have implications in the development of antiviral drugs targeting transcription or replication of negative stranded RNA viruses.
    Keywords Hantavirus ; antiviral agents ; binding sites ; cell culture ; culture media ; fever ; messenger RNA ; people ; plasmids ; rodents ; vaccines ; virus replication ; viruses ; Eurasia ; North America ; South America
    Language English
    Dates of publication 2018-12
    Size p. 18.
    Publishing place BioMed Central
    Document type Article
    ISSN 1743-422X
    DOI 10.1186/s12985-018-0932-8
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Quantification and kinetics of viral RNA transcripts produced in Orthohantavirus infected cells.

    Wigren Byström, Julia / Näslund, Jonas / Trulsson, Fredrik / Evander, Magnus / Wesula Lwande, Olivia / Ahlm, Clas / Bucht, Göran

    Virology journal

    2018  Volume 15, Issue 1, Page(s) 18

    Abstract: Background: Rodent borne viruses of the Orthohantavirus genus cause hemorrhagic fever with renal syndrome among people in Eurasia, and hantavirus cardiopulmonary syndrome in the Americas. At present, there are no specific treatments or efficient ... ...

    Abstract Background: Rodent borne viruses of the Orthohantavirus genus cause hemorrhagic fever with renal syndrome among people in Eurasia, and hantavirus cardiopulmonary syndrome in the Americas. At present, there are no specific treatments or efficient vaccines against these diseases. Improved understanding of viral transcription and replication may instigate targeted treatment of Orthohantavirus infections. For this purpose, we investigated the kinetics and levels of viral RNA transcription during an ongoing infection in-vitro.
    Methods: Vero E6 cells were infected with Puumala Orthohantavirus (strain Kazan) before cells and supernatants were collected at different time points post infection for the detection of viral RNAs. A plasmid containing primer binding sites of the three Orthohantavirus segments small (S), medium (M) and large (L) was constructed and standard curves were generated to calculate the copy numbers of the individual transcripts in the collected samples.
    Results: Our results indicated a rapid increase in the copy number of viral RNAs after 9 h post infection. At peak days, 2-6 days after infection, the S- and M-segment transcripts became thousand and hundred-fold more abundant than the copy number of the L-segment RNA, respectively. The presence of viral RNA in the cell culture media was detected at later time-points.
    Conclusions: We have developed a method to follow RNA transcription in-vitro after synchronous infection of Vero cells. The obtained results may contribute to the understanding of the viral replication, and may have implications in the development of antiviral drugs targeting transcription or replication of negative stranded RNA viruses.
    MeSH term(s) Animals ; Cercopithecus aethiops ; Gene Expression Regulation, Viral ; Genetic Vectors/genetics ; Hantavirus/physiology ; Hantavirus Infections/virology ; RNA, Viral/genetics ; Transcription, Genetic ; Vero Cells ; Virus Replication
    Chemical Substances RNA, Viral
    Language English
    Publishing date 2018-01-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1743-422X
    ISSN (online) 1743-422X
    DOI 10.1186/s12985-018-0932-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top